EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market,
The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs, who shared this optimistic…
Read More...
Read More...